GSK earnings date and last-quarter result: next report 2026-07-28, last quarter beat, P/E 13.11. Updated 2026-07-23.
GSK (GSK) Research Hub
GSK (GSK) trades on NYSE, GB in the Healthcare (Drug Manufacturers - General) sector. As of 2026-10-26, shares last closed at 51.1 USD (+0.69%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 13.11, market cap 101.87B. This hub links to the full technical, earnings and options research available for GSK.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - General) |
|---|---|
| Exchange | NYSE, GB |
| Last close | 51.1 USD (+0.69%) |
| 52-week range | 45.83 USD – 55.79 USD |
| Trend regime | Range |
| 14-day RSI | 74.8 (Overbought) |
| Trailing P/E | 13.11 |
| Market cap | 101.87B |
| Dividend yield | 3.52% |
| Next earnings | 2026-07-28 |
Available research for GSK
Covered Call on GSK: how it works, illustrative setup around the real 51.1 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GSK: how it works, illustrative setup around the real 51.1 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GSK: how it works, illustrative setup around the real 51.1 USD price, max profit/loss, breakeven and when to use it. Educational.
GSK technical analysis: range, last 51.1 USD, RSI 74.8, 52w range 45.83 USD–55.79 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is GSK in?
GSK (GSK) is classified under Healthcare (Drug Manufacturers - General), listed on NYSE, GB.
Is GSK in an uptrend or downtrend?
As of 2026-10-26, GSK is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GSK's trailing P/E ratio?
GSK's trailing P/E is 13.11, with a market cap of 101.87B. See the earnings research page for full valuation detail.
When does GSK next report earnings?
GSK is next scheduled to report earnings on 2026-07-28.